BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $673,000 | -72.4% | 16,396 | -74.3% | 0.31% | -73.6% |
Q4 2015 | $2,439,000 | +13.7% | 63,911 | -2.1% | 1.17% | +5.1% |
Q3 2015 | $2,145,000 | -57.4% | 65,299 | -9.3% | 1.11% | -50.2% |
Q2 2015 | $5,036,000 | -2.0% | 72,025 | -4.0% | 2.23% | +2.4% |
Q1 2015 | $5,139,000 | -19.6% | 75,014 | -13.9% | 2.18% | -8.2% |
Q4 2014 | $6,388,000 | +25.8% | 87,156 | +23.2% | 2.37% | +23.4% |
Q3 2014 | $5,076,000 | +4.0% | 70,723 | +4.7% | 1.92% | +4.8% |
Q2 2014 | $4,883,000 | +4.5% | 67,545 | +6.4% | 1.83% | -0.2% |
Q1 2014 | $4,672,000 | +61.9% | 63,504 | +53.0% | 1.84% | +60.1% |
Q4 2013 | $2,886,000 | +29.1% | 41,497 | +21.9% | 1.15% | +19.6% |
Q3 2013 | $2,236,000 | – | 34,044 | – | 0.96% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |